header advert
Bone & Joint Open Logo

Receive monthly Table of Contents alerts from Bone & Joint Open

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Bone & Joint Open at:

Loading...

Loading...

Open Access

Knee

Cementless total knee arthroplasty in young patients using tantalum trabecular implants results in significantly lower rates of aseptic loosening

a series of 454 total knee arthroplasties with a mean follow-up of ten years



Download PDF

Abstract

Aims

The mean age of patients undergoing total knee arthroplasty (TKA) has reduced with time. Younger patients have increased expectations following TKA. Aseptic loosening of the tibial component is the most common cause of failure of TKA in the UK. Interest in cementless TKA has re-emerged due to its encouraging results in the younger patient population. We review a large series of tantalum trabecular metal cementless implants in patients who are at the highest risk of revision surgery.

Methods

A total of 454 consecutive patients who underwent cementless TKA between August 2004 and December 2021 were reviewed. The mean follow-up was ten years. Plain radiographs were analyzed for radiolucent lines. Patients who underwent revision TKA were recorded, and the cause for revision was determined. Data from the National Joint Registry for England, Wales, Northern Island, the Isle of Man and the States of Guernsey (NJR) were compared with our series.

Results

No patients in our series had evidence of radiolucent lines on their latest radiological assessment. Only eight patients out of 454 required revision arthroplasty, and none of these revisions were indicated for aseptic loosening of the tibial baseplate. When compared to data from the NJR annual report, Kaplan-Meier estimates from our series (2.94 (95% confidence interval (CI) 1.24 to 5.87)) show a significant reduction in cumulative estimates of revision compared to all cemented (4.82 (95% CI 4.69 to 4.96)) or cementless TKA (5.65 (95% CI 5.23 to 6.10)). Our data (2.94 (95% CI 1.24 to 5.87)) also show lower cumulative revision rates compared to the most popular implant (PFC Sigma Cemented Knee implant fixation, 4.03 (95% CI 3.75 to 4.33)). The prosthesis time revision rate (PTIR) estimates for our series (2.07 (95% CI 0.95 to 3.83)) were lower than those of cemented cases (4.53 (95% CI 4.49 to 4.57)) from NJR.

Conclusion

The NexGen trabecular (tantalum) cementless implant has lower revision rates in our series compared to all cemented implants and other types of cementless implants, and its use in younger patients should be encouraged.

Cite this article: Bone Jt Open 2024;5(4):277–285.

Take home message

The use of a uncemented trabecular metal total knee arthroplasty should be considered in younger patients who have an increased lifetime risk of revision surgery, as it significantly reduces the chance of aseptic loosening versus cemented implants, thereby improving implant longevity.

Introduction

Total knee arthroplasty (TKA) is a well-established procedure for end-stage osteoarthritis (OA) of the knee joint.1,2 Failure after TKA may be for a variety of different reasons, with the most common indications including aseptic loosening, periprosthetic joint infection, pain, and instability.3,4 Aseptic loosening has become the most common failure mode and indication for revision surgery in the UK.5 Aseptic loosening of the tibial component is seen more frequently than femoral loosening, and has been linked to poor cementing technique and a lack of cement bonding to the tibial component.6

Cementless TKA was thought to be a solution to this problem, but unfortunately outcomes did not replicate the early enthusiasm. Failures were multifactorial and differed depending on implant design. The first-generation polyethylene was vulnerable to wear with subsequent osteolysis.7 Some cementless implant designs had a high failure rate secondary to poor fixation, leading to early implant migration and loosening of the tibial component.8,9 Modern polyethylene manufacturing and design have greatly reduced the concerns about polyethylene wear, and therefore concerns are rightly now more focused on implant fixation.

The mean age of patients undergoing TKA has reduced with time.10 Analysis of the National Joint Registry for England, Wales, Northern Ireland, and the Isle of Man (NJR) shows a significantly increased risk of revision in younger patients receiving TKA.5 Given the increased costs, morbidity, and poorer outcomes of revision TKA compared to primary TKA, every effort should be made to reduce the risk of revision in this challenging group of patients.11-13

The NexGen Cementless Implant (Trabecular Metal Monoblock Tibia; Zimmer Biomet, USA) has been in use for almost two decades. It incorporates a tantalum trabecular mesh that has a modulus of elasticity comparable to the cancellous bone.14 Enhanced osseointegration seen with the tantalum implant results in decreased stress shielding, higher resistance against shear forces, and improved implant fixation.15,16 These properties potentially reduce the risk of aseptic loosening, making this implant an attractive choice in younger, higher-demand patients. The femoral component is porous-coated, and does not incorporate trabecular metal; previous studies have demonstrated that femoral component loosening is much less of a concern compared to tibial component loosening with both cemented and cementless TKA designs.17

The aim of this study was to review a large consecutive case series of NexGen tantalum trabecular metal cementless TKA. We investigate the modes of failure, particularly aseptic loosening of the tibial baseplate. We compared our series with conventional cemented and cementless TKA performed in the UK by using existing data from the NJR. We hypothesize that the use of trabecular metal uncemented implants would reduce the revision rates, specifically in younger population.

Methods

We performed a retrospective review of a prospectively kept database, including all cementless TKA procedures performed at a single district general hospital and the senior authors’ independent practice within the UK. All consecutive cementless NexGen TKA performed between August 2004 and December 2021 were included in the study.

We sourced NJR data and followed their guidelines. Patient data for our database had been recorded as a part of routine hospital practice over the years. While the data were collected, the patients gave consent for its use for research purpose. We did not collect new data from the patients.

Inclusion and exclusion criteria for the study are shown in Table I and patient selection is depicted in the flowchart (Figure 1). A cementless implant was preferred over a cemented implant in young, high-demand patients with good bone stock on the radiographs, and pre-menopausal women with no concerns about osteoporosis.

Table I.

Selection criteria.

Inclusion criteria Exclusion criteria
Patient consent obtained Patients who underwent TKA for other diagnoses except OA
Patient diagnosed with OA including traumatic OA Patients mistakenly registered as cementless, originally cemented TKA
Patient undergoing primary TKA Mobile-bearing cementless prostheses with various modes of fixation, or other brands or designs
Cementless NexGen implant used (cruciate-retaining type and posterior-stabilizing type) Patients who declined to be registered on the NJR
Ongoing engagement and traceability for revisions on the NJR Patients without notes or radiographs
Complex bilateral primary knee arthroplasty
  1. NJR, National Joint Registry; OA, osteoarthritis; TKA, total knee arthroplasty.

Fig. 1 
          Flowchart depicting the selection of cases for the study. NJR, National Joint Registry; TKA, total knee arthroplasty.

Fig. 1

Flowchart depicting the selection of cases for the study. NJR, National Joint Registry; TKA, total knee arthroplasty.

Surgery was performed using a standard medial parapatellar approach. The NexGen (Zimmer Biomet, USA) tantalum trabecular-mesh monoblock tibial implant was used in all patients, combined with the cementless NexGenporous coated femoral component. Patellar resurfacing was not performed as part of the primary procedure in any patients. Patients were encouraged to mobilize from day one postoperatively, and full range of motion was allowed as tolerated. All patients had regular outpatient surveillance in an arthroplasty nurse specialist-led clinic with routine five-yearly radiographs.

All patients underwent radiological evaluation of their TKA at time of final follow-up. The presence of radiolucent lines around the femoral and tibial components was assessed using a zone specific American Knee Society radiological evaluation score recommendation, which has been modified specifically for the pegged tibial baseplate design used in this study.18-20

Electronic patient records in conjunction with radiographs and surgeons’ individual NJR data were used to identify any reoperations or revision of components. Individual NJR surgeon reports were reviewed to ensure completeness of data, and all index linked revisions were viewed to establish cause of revision. The NJR tracks all patients regardless of where the subsequent revision surgery is performed, and therefore we were able to identify patients who underwent revision of the primary TKA in other units across the UK.

Our revision rate was defined as revision of TKA due to implant-related causes for any reason. Secondary patella resurfacing was classed as a reoperation rather than a revision, due to implant failure for the purpose of this study.

Statistical analysis

Patients’ data was anonymized to protect identity. Statistical analysis was performed by a senior statistician (AS) associated with the University using SAS Version 9.4 of the SAS System for Windows (SAS Institute Inc. 2016. Base SAS 9.4 Procedures Guide, USA). Kaplan-Meier (KM) estimates of cumulative survival and revision of knee implants were calculated. Prosthesis time incidence rate (PTIR) in terms of the number of revisions per 1,000 prosthesis years was also calculated. Due to the small size of the dataset, and particularly the small number of revisions observed, skewness-corrected asymptotic score method (SCAS) was used to calculate the PTIR estimates and their confidence intervals.21 Data were split by patient age at original arthroplasty, looking primarily at those aged 64 years and under, and those aged 65 years and over.

Results

Complete datasets were available for analysis in 454 patients (389 male, 65 female) who underwent TKA using the NexGen tantalum trabecular mesh implants between August 2004 and December 2021. The mean age was 59 years (22 to 78) with the majority of patients falling between 54 and 64 years (Figure 2).

Fig. 2 
          Age distribution of cementless primary knee arthroplasty patients.

Fig. 2

Age distribution of cementless primary knee arthroplasty patients.

In total, 41 patients received a cruciate-retaining (CR) implant while the rest (n = 413) had a posterior-stabilizing (PS) prosthesis.

Only eight patients required revision arthroplasty (Table II). Overall, the revision rate was 1.76% and the cumulative revision rate was 2.94% (1.24 to 5.87) at 17 years. Most importantly, no patients required revision for aseptic loosening of the tibial baseplate. There was no evidence of radiolucent lines in any patients on latest radiological assessment.

Table II.

Reasons for revising the uncemented total knee arthroplasty.

Cause of revision Number of cases Age at primary surgery, yrs Year of primary procedure Implant survival, yrs
Femoral component loosening 2 53 2005 11.4
68 2009 3.5
Instability* 4 45 2009 9.5
57 2004 7.6
62 2015 1.38
66 2012 5.6
Stiffness 2 54 2008 1.3
56 2005 1.2
  1. *

    Instability was defined clinically, and there was no evidence of component loosening or malalignment on radiological evaluations.

There was a single patient who required a secondary patella resurfacing due to persistent postoperative anterior knee pain, but there was no evidence of femoral or tibial component loosening both radiologically and intraoperatively.

KM estimates for implant survival (Figure 3) and separate curves for age distribution (≤ 64 years, and ≥ 65 years) (Figure 4) showed similar trends. KM estimates of cumulative revision are comparable in both age groups (Table III). Table IV shows the overall follow-up duration for all patients.

Fig. 3 
          Kaplan-Meier estimates of cumulative survival in cementless primary knee arthroplasties.

Fig. 3

Kaplan-Meier estimates of cumulative survival in cementless primary knee arthroplasties.

Fig. 4 
          Kaplan-Meier estimates of cumulative survival by age, in cementless primary knee arthroplasties.

Fig. 4

Kaplan-Meier estimates of cumulative survival by age, in cementless primary knee arthroplasties.

Table III.

Kaplan-Meier estimates of cumulative revision (95% confidence interval) by age group in primary knee arthroplasties.

Age at primary knee arthroplasty, yrs N Time since primary knee arthroplasty, yrs
1 3 5 10 15 17
≤ 64 350 0.00

(N/A)
0.89

(0.25 to 2.42)
0.89

(0.25 to 2.42)
2.15

(0.74 to 4.96)
3.27

(1.15 to 7.28)
3.27

(1.15 to 7.28)
≥ 65 104 0.00

(N/A)
0.00

(N/A)
1.03

(0.09 to 5.08)
2.24

(0.42 to 7.13)
2.24

(0.42 to 7.13)
2.24

(0.42 to 7.13)
  1. Where there are patients at risk, but no events, the absolute risk is estimated as 0 and the confidence interval cannot be estimated. It is denoted by "(N/A)".

  1. N/A, not applicable.

Table IV.

Number of patients as per follow-up duration.

Age at primary knee arthroplasty, yrs 1 yr 3 yrs 5 yrs 10 yrs 15 yrs 17 yrs
≤ 64 350 319 280 135 37 16
≥ 65 104 99 92 43 19 12

Our data shows a significant reduction in cumulative estimates of revision compared to all cemented or cementless TKA from the NJR (Table V). This is despite a mean age of 58.6 years in our dataset in comparison to a mean national age for primary TKA of 69.7 years (cemented) and 68.2 years (cementless).

Table V.

Kaplan-Meier estimates of cumulative revision (95% confidence interval) by fixation in primary knee arthroplasties.

Data source Mean age, yrs

(SD)
Fixation N Time since primary knee arthroplasty, yrs
1 3 5 10 15 17
NJR 68.9

(9.6)
All types 1,357,077 0.49

(0.48 to 0.51)
1.75

(1.73 to 1.77)
2.54

(2.51 to 2.57)
4.13

(4.08 to 4.17)
5.84

(5.75 to 5.93)
6.43

(6.29 to 6.57)
69.7

(9.3)
All cemented 1,136,212 0.42

(0.41 to 0.43)
1.48

(1.45 to 1.50)
2.11

(2.08 to 2.14)
3.23

(3.19 to 3.27)
4.14

(4.33 to 4.50)
4.82

(4.69 to 4.96)
68.2

(9.6)
All uncemented 47,061 0.56

(0.50 to 0.64)
2.09

(1.96 to 2.23)
2.84

(2.68 to 3.00)
4.06

(3.86 to 4.27)
5.35

(5.05 to 5.86)
5.65

(5.23 to 6.10)
Our series 58.6

(8.07)
All uncemented 454 0.00

(N/A)
0.68

(0.19 to 1.87)
0.93

(0.31 to 2.24)
2.17

(0.91 to 4.40)
2.94

(1.24 to 5.87)
2.94

(1.24 to 5.87)
  1. Where there are patients at risk, but no events, the absolute risk is estimated as 0 and the confidence interval cannot be estimated. It is denoted by "(N/A)".

  1. N/A, not applicable; NJR, National Joint Registry; SD, standard deviation.

When comparing the KM estimates of the cumulative revision rate by implant brand (implanted on at least 2,500 occasions), our data show lower rates when compared to the most popular cemented implant (PFC Sigma Cemented Knee implant fixation) and when compared to other cementless implants (Table VI and Table VII). We have excellent outcomes compared to the national data for the NexGen Tibia Monoblock (Table VII).

Table VI.

Kaplan-Meier estimates of cumulative revision (95% confidence interval) in primary knee arthroplasties using PFC Sigma (cemented) vs our series.

Data source Brand N Time since primary knee arthroplasty, yrs
1 3 5 10 15 17
NJR PFC Sigma Bicondylar Knee (femoral) PFC Bicondylar (tibial)
Cemented, unconstrained, fixed 132,331 0.39

(0.36 to 0.42)
1.23

(1.17 to 1.29)
1.70

(1.62 to 1.77)
2.36

(2.26 to 2.45)
3.02

(2.88 to 3.17)
3.19

(3.01 to 3.37)
Cemented, PS, fixed 36,344 0.40

(0.34 to 0.47)
1.49

(1.37 to 1.62)
2.05

(1.91 to 2.21)
2.99

(2.80 to 3.19)
4.03

(3.75 to 4.33)
4.54

(4.02 to 5.13)
PFC Sigma Bicondylar Knee (femoral) PFC Sigma Bicondylar (tibial)
Cemented, unconstrained, fixed 122,269 0.35

(0.32 to 0.38)
1.34

(1.27 to 1.41)
1.87

(1.79 to 1.95)
2.50

(2.39 to 2.62)
Our series All uncemented 454 0.00

(N/A)
0.68

(0.19 to 1.87)
0.93

(0.31 to 2.24)
2.17

(0.91 to 4.40)
2.94

(1.24 to 5.87)
2.94

(1.24 to 5.87)
  1. Where there are patients at risk, but no events, the absolute risk is estimated as 0 and the confidence interval cannot be estimated. It is denoted by "(N/A)". Where fewer than ten patients are at risk, the cell is left blank.

  1. N/A, not applicable; NJR, National Joint Registry.

Table VII.

Kaplan-Meier estimates of cumulative revision (95% confidence interval) by brand, in primary knee arthroplasties.

Data source Brand N Time since primary knee arthroplasty, yrs
1 3 5 10 15 17
NJR LCS Complete (femoral) M.B.T. (tibial)
Uncemented, unconstrained, mobile 15,831 0.42

(0.33 to 0.54)
1.83

(1.63 to 2.06)
2.53

(2.28 to 2.80)
3.43

(3.12 to 3.77)
4.11

(3.67 to 4.61)
Nexgen (femoral) TM Monoblock (tibial)
Uncemented, unconstrained, fixed 4,002 0.61

(0.41 to 0.90)
2.62

(2.16 to 3.17)
3.33

(2.81 to 3.96)
4.39

(3.76 to 5.12)
4.98

(4.24 to 5.84)
4.98

(4.24 to 5.84)
Scorpio (femoral) Scorpio NRG (tibial)
Uncemented, unconstrained, fixed 3,733 0.62

(0.41 to 0.93)
1.93

(1.53 to 2.43)
2.61

(2.14 to 3.18)
3.93

(3.33 to 4.63)
4.74

(4.02 to 5.58)
4.74

(4.02 to 5.58)
Triathlon (femoral; tibial)
Uncemented, unconstrained, fixed 4,190 0.61

(0.41 to 0.91)
1.70

(1.30 to 2.23)
2.15

(1.64 to 2.82)
3.07

(2.07 to 4.54)
Our series All uncemented (NexGen (femoral; tibial)) 454 0.00

(N/A)
0.68

(0.19 to 1.87)
0.93

(0.31 to 2.24)
2.17

(0.91 to 4.40)
2.94

(1.24 to 5.87)
2.94

(1.24 to 5.87)
  1. Where there are patients at risk, but no events, the absolute risk is estimated as 0 and the confidence interval cannot be estimated. It is denoted by "(N/A)". Where fewer than ten patients are at risk, the cell is left blank.

  1. N/A, not applicable.

PTIR is defined as the number of revisions per population at risk in a given time period, and expressed as the number of revisions per 100 patient years at risk.22 The PTIR estimates with SCAS for our series is lower than the national rate for both uncemented and cemented TKA (Table VIII).

Table VIII.

Prosthesis time incident rate estimates of indications for revision (95% confidence interval) by fixation, constraint, bearing type, and whether a patella component was recorded.

Data source Fixation, constraint, and bearing subgroups Mean age, yrs Prosthesis years at risk (× 1,000) Total revisions Number of revisions per 1,000 prosthesis years (all causes) with SCAS CI*
NJR All cases 70 8,921.4 40,414 4.53 (4.49 to 4.57)
All cemented 70 7,353.0 26,618 3.62 (3.58 to 3.66)
Cemented: PS, fixed, with patella All ages 900.3 3,259 3.62 (3.50 to 3.75)
Cemented: PS, fixed, without patella All ages 887.6 4,385 4.94 (4.80 to 5.09)
All uncemented All ages 386.8
Our series All uncemented 59 4.0 8 2.07 (0.95 to 3.83)
Uncemented ≤ 64 3.0 6 2.09 (0.83 to 4.21)
Uncemented ≥ 65 1.0 2 2.19 (0.36 to 6.60)
  1. *

    This CI method takes into account the skewed distribution of the number of revisions, resulting in a narrower interval.

  1. CI, confidence interval; NJR, National Joint Registry; PS, posterior-stabilizing; SCAS, skewness-corrected asymptotic score.

Discussion

For patients with end-stage OA, TKA remains the gold-standard method of treatment.1,2 The mean age of the patients who undergo TKA has decreased over time.10,23 Early cementless TKA implants were often associated with increased failures, largely due to poor implant designs.24 Aseptic loosening of the tibial component and inadequate bone ingrowth were common causes of failure.2,17 Studies using titanium alloy-based porous implants published in the 1990s and early 2000 showed poor results, with high implant failure, inferior clinical outcomes, and poor osseointegration.17,25,26

Data from the NJR show that the preference for cementless fixation has been decreasing since 2004. The 20th annual NJR report shows that 95.47% of all TKAs performed in the UK are fully cemented.5 This is despite studies with smaller cohorts showing comparable results between cementless tibial component and fully cemented TKA, with no significant differences between the porous femoral component and cemented femoral component. Studies focusing on patients below the age of 65 years have shown superior results for cementless implants in terms of implant failure and revision rates compared to cemented TKA, while conventional implants have higher failure rates in the younger population compared to older population.27 A single-blinded randomized controlled trial published in 2020 by one of our authors in a different unit compared the cementless tantalum monoblock tibia fixation device (NexGen TMT, Zimmer Biomet) against a conventional cemented tibial component (Option Tibia, Zimmer Biomet) for a mean follow-up of 13.2 years.28 They found that while there was a significant improvement in Knee Society Score and Oxford Knee Score after TKA in both groups, there was a gradual decrease in scores in the cemented group over time. Radiological analysis also demonstrated a marked difference in both groups, with significantly more radiolucency seen beneath tibial trays in the cemented group.

Despite the more recent encouraging data, surgeons remain hesitant to adopt the use of cementless implant fixation for younger patients. This could be due to higher implant costs compared to cheaper, dependable cemented implants. However, evidence shows that the cost difference is not significant when shorter operating time and reduced expendables are taken into consideration.20,24,29 Our data suggest that the use of cementless TKA may significantly reduce the risk of revision TKA in a high-risk group of patients, and therefore the high costs associated with revision TKA should also be taken into consideration.

In the cohort presented here, cementless TKA was performed predominately in male patients with a mean age below 59 years. Both male sex and young age are directly related to an increased risk of revision TKA.5 Increased levels of activity of in younger patients places more stress on the bone implant interface, which can lead to premature loosening of the components, which may be the reason aseptic loosening is the major cause for revision in this age group.30 Despite this, we experienced no cases of aseptic loosening of tibial component, and a very modest revision rate of 1.76% in the whole cohort.

The 18th annual NJR report shows comparable revision rates between cemented and cementless implants in patients below the age of 65 years. This is contrary to the results in our study, with significantly better revision rates than those reported in the NJR (Table V). The NexGen implant has a higher reported failure rate (4.98) versus our data (2.94). We believe this is due to being selective over the patients who receive a cementless implant, specifically young male, pre-menopausal women, and non-smokers, who will have better bone biology compared to the routine cohort.

We almost exclusively used PS implants in our reported cohort, despite the NJR showing an increased revision rate for PS versus CR cemented implants.31 The senior author (AJA) concludes that poor cementing technique in a PS implant will result in a higher failure rate. Considering that our series involves uncemented fixation, we are able to avoid this problem. The tantalum metal osseointegrates excellently with native bone, resulting in a stable and long-lasting fixation.

Cementless implants aid in preserving the native bone stock, and incorporate the physiological healing process, thus delivering superior osseointegration. The surgical time is shortened, which could be advantageous in reducing the pneumatic tourniquet time for surgeons who perform surgery using a tourniquet. The initial stability and fixation of trabecular metal is excellent, which allows for the twin pegged design of the tibial baseplate, when compared to the keel required for rotational stability in cemented baseplates; this potentially allows for an easier bone-sparing revision in the event of failure.29 Avoiding cement also prevents cement-related complications both perioperatively and later due to cement debris. Cementless implants can withstand higher shearing forces compared to cemented implants, as they transmit the stress onto native bone, encouraging bone growth and remodelling, whereas the cement-bone interface wears out over time. Once osseointegrated, the concern about shear stress and increased constrained becomes irrelevant.32 Tantalum has low rates of infection compared to other metallic components. The porous metal results in decreased bacterial adherence and reduction in biofilm production.33

Despite the advantages of cementless implants, there is paucity of data about its long-term survival in large centre studies. Currently available studies focus mainly on the older generation of cementless implants, which experienced high rates of failure.7-9 The common causes for revision of cementless TKA knees include pain, aseptic loosening/lysis, and wear. Nevertheless, compared to cemented implants, the rates of revision due to implant infection are lower.

The tibial monoblock carries the risk of instability and stiffness due to its design, lacking modularity once the femoral and tibial components are in place, and does not allow for an isolated exchange of polyethylene insert in case of instability that requires revision surgery.2 Four of our patients experienced instability, and one patient had stiffness for which they underwent revision TKA. In our case series, we encountered only two cases of aseptic loosening of the femoral component. The radiographs were normal in each case and showed no implant migration, but the femoral components were thought to be loose intraoperatively at the time of revision surgery. In our study, 41 patients were implanted with the CR type of NexGen implant, while the rest were implanted with the PS type. Studies have shown that both varieties have similar outcomes.34

This study does have limitations. Its retrospective nature means that datasets may not be complete, however we used a prospective database and carefully analyzed individual surgeons’ NJR data, and therefore believe our dataset to be complete. This study specifically investigates the outcomes of a Tantalum trabecular metal tibial component, and our results may not be applicable to other cementless designs. We did not collect functional outcome scores in this study that would have been of interest; however, the aim of this study was to determine if revision and aseptic loosing rates were reduced by the use of this specific implant and, most importantly, we seem to have addressed the problem of tibial aseptic loosening.

In conclusion, cementless TKA is an attractive choice for younger (< 65 years), more active patients, and has excellent survivorship. The NexGen trabecular (tantalum) cementless implant has lower revision rates in our series compared to all cemented implants and other types of cementless implants, and its use in younger patients should be encouraged.


Correspondence should be sent to Vatsal Khetan. E-mail:

References

1. Berger RA , Rosenberg AG , Barden RM , Sheinkop MB , Jacobs JJ , Galante JO . Long-term followup of the Miller-Galante total knee replacement . Clin Orthop Relat Res . 2001 ; 388 ( 388 ): 58 67 . Crossref PubMed Google Scholar

2. Niemeläinen M , Skyttä ET , Remes V , Mäkelä K , Eskelinen A . Total knee arthroplasty with an uncemented trabecular metal tibial component . J Arthroplasty . 2014 ; 29 ( 1 ): 57 60 . Crossref PubMed Google Scholar

3. Sharkey PF , Lichstein PM , Shen C , Tokarski AT , Parvizi J . Why are total knee arthroplasties failing today—has anything changed after 10 years? J Arthroplasty . 2014 ; 29 ( 9 ): 1774 1778 . Crossref PubMed Google Scholar

4. Narkbunnam R , Chareancholvanich K . Causes of failure in total knee arthroplasty . J Med Assoc Thai . 2012 ; 95 ( 5 ): 667 673 . PubMed Google Scholar

5. Ben-Shlomo Y , Blom A , Clark E , et al. NJR 20th Annual Report 2023 , London, UK : National Joint Registry . https://reports.njrcentre.org.uk/Portals/0/PDFdownloads/NJR%2020th%20Annual%20Report%202023.pdf ( date last accessed 4 April 2024 ). Google Scholar

6. Arsoy D , Pagnano MW , Lewallen DG , Hanssen AD , Sierra RJ . Aseptic tibial debonding as a cause of early failure in a modern total knee arthroplasty design . Clin Orthop Relat Res . 2013 ; 471 ( 1 ): 94 101 . Crossref PubMed Google Scholar

7. Ritter MA , Meneghini RM . Twenty-year survivorship of cementless anatomic graduated component total knee arthroplasty . J Arthroplasty . 2010 ; 25 ( 4 ): 507 513 . Crossref PubMed Google Scholar

8. Gandhi R , Tsvetkov D , Davey JR , Mahomed NN . Survival and clinical function of cemented and uncemented prostheses in total knee replacement . J Bone Joint Surg Br . 2009 ; 91-B ( 7 ): 889 895 . Crossref PubMed Google Scholar

9. Cloke DJ , Khatri M , Pinder IM , McCaskie AW , Lingard EA . 284 press-fit Kinemax total knee arthroplasties followed for 10 years: poor survival of uncemented prostheses . Acta Orthopaedica . 2008 ; 79 ( 1 ): 28 33 . Crossref PubMed Google Scholar

10. Laskin RS . Session III: Total knee replacement in young patients . Clin Orthop Relat Res . 2002 ; 404 ( 404 ): 100 101 . Crossref PubMed Google Scholar

11. Kallala RF , Vanhegan IS , Ibrahim MS , Sarmah S , Haddad FS . Financial analysis of revision knee surgery based on NHS tariffs and hospital costs: does it pay to provide a revision service? Bone Joint J . 2015 ; 97-B ( 2 ): 197 201 . Crossref PubMed Google Scholar

12. Wang CJ , Hsieh MC , Huang TW , Wang JW , Chen HS , Liu CY . Clinical outcome and patient satisfaction in aseptic and septic revision total knee arthroplasty . The Knee . 2004 ; 11 ( 1 ): 45 49 . Crossref PubMed Google Scholar

13. Sadoghi P , Liebensteiner M , Agreiter M , Leithner A , Böhler N , Labek G . Revision surgery after total joint arthroplasty: a complication-based analysis using worldwide arthroplasty registers . J Arthroplasty . 2013 ; 28 ( 8 ): 1329 1332 . Crossref PubMed Google Scholar

14. Paganias CG , Tsakotos GA , Koutsostathis SD , Macheras GA . Osseous integration in porous tantalum implants . Indian J Orthop . 2012 ; 46 ( 5 ): 505 513 . Crossref PubMed Google Scholar

15. Bobyn JD , Stackpool GJ , Hacking SA , Tanzer M , Krygier JJ . Characteristics of bone ingrowth and interface mechanics of a new porous tantalum biomaterial . J Bone Joint Surg Br . 1999 ; 81-B ( 5 ): 907 914 . Crossref PubMed Google Scholar

16. Cohen R . A porous tantalum trabecular metal: basic science . Am J Orthop (Belle Mead NJ) . 2002 ; 31 ( 4 ): 216 217 . PubMed Google Scholar

17. Berger RA , Lyon JH , Jacobs JJ , et al. Problems with cementless total knee arthroplasty at 11 years followup . Clin Orthop Relat Res . 2001 ; 392 : 196 207 . Crossref PubMed Google Scholar

18. Sarmah SS , Patel S , Hossain FS , Haddad FS . The radiological assessment of total and unicompartmental knee replacements . J Bone Joint Surg Br . 2012 ; 94-B ( 10 ): 1321 1329 . Crossref PubMed Google Scholar

19. Ewald FC . The Knee Society total knee arthroplasty roentgenographic evaluation and scoring system . Clin Orthop Relat Res . 1989 ; 248 ( 248 ): 9 12 . Crossref PubMed Google Scholar

20. Kamath AF , Lee GC , Sheth NP , Nelson CL , Garino JP , Israelite CL . Prospective results of uncemented tantalum monoblock tibia in total knee arthroplasty: minimum 5-year follow-up in patients younger than 55 years . J Arthroplasty . 2011 ; 1;26(8 : 1390 1395 . Crossref PubMed Google Scholar

21. Laud PJ . Equal‐tailed confidence intervals for comparison of rates . Pharmaceutical Statistics . 2017 ; 16 ( 5 ): 334 348 . Crossref PubMed Google Scholar

22. No authors listed . NJR Implant Performance Analysis Methodology . National Joint Registry . 2017 . https://www.njrcentre.org.uk/wp-content/uploads/2017-08-22-NJR-Implant-Performance-Analysis-Methodology.pdf ( date last accessed 4 April 2024 ). Google Scholar

23. Aggarwal VK , Goyal N , Deirmengian G , Rangavajulla A , Parvizi J , Austin MS . Revision total knee arthroplasty in the young patient: is there trouble on the horizon? JBJS . 2014 ; 96 ( 7 ): 536 542 . Crossref PubMed Google Scholar

24. Aprato A , Risitano S , Sabatini L , Giachino M , Agati G , Massè A . Cementless total knee arthroplasty . Ann Transl Med . 2016 ; 4 ( 7 ): 129 . Crossref PubMed Google Scholar

25. Moran CG , Pinder IM , Lees TA , Midwinter MJ . Survivorship analysis of the uncemented porous-coated anatomic knee replacement . J Bone Joint Surg Am . 1991 ; 73-A ( 6 ): 848 857 . Crossref PubMed Google Scholar

26. Nafei A , Nielsen S , Kristensen O , Hvid I . The press-fit Kinemax knee arthroplasty. High failure rate of non-cemented implants . J Bone Joint Surg Br . 1992 ; 74-B ( 2 ): 243 246 . Crossref PubMed Google Scholar

27. Wang K , Sun H , Zhang K , et al. Better outcomes are associated with cementless fixation in primary total knee arthroplasty in young patients . Medicine (Baltimore) . 2020 ; 99 ( 3 ): e18750 . Crossref PubMed Google Scholar

28. Hampton M , Mansoor J , Getty J , Sutton PM . Uncemented tantalum metal components versus cemented tibial components in total knee arthroplasty: 11- to 15-year outcomes of a single-blinded randomized controlled trial . Bone Joint J . 2020 ; 102-B ( 8 ): 1025 1032 . Crossref PubMed Google Scholar

29. Matassi F , Carulli C , Civinini R , Innocenti M . Cemented versus cementless fixation in total knee arthroplasty . Joints . 2013 ; 1 ( 3 ): 121 125 . Crossref PubMed Google Scholar

30. Harrysson OLA , Robertsson O , Nayfeh JF . Higher cumulative revision rate of knee arthroplasties in younger patients with osteoarthritis . Clin Orthop Relat Res . 2004 ; 421 ( 421 ): 162 168 . Crossref PubMed Google Scholar

31. Leppo S . Urgent medical device recall . Zimmer Biomet . December 6 , 2022 . https://www.zimmerbiomet.com/content/dam/zb-corporate/en/products/specialties/knee/nexgen-complete-knee-solution/zfa_2022-00240_risk-manager-and-surgeon-letter.pdf ( date last accessed 25 January 2024 ). Google Scholar

32. Patel MS , McCormick JR , Ghasem A , Huntley SR , Gjolaj JP . Tantalum: the next biomaterial in spine surgery? J Spine Surg . 2020 ; 6 ( 1 ): 72 86 . Crossref PubMed Google Scholar

33. Chen X , Bi Y , Huang M , Cao H , Qin H . Why is tantalum less susceptible to bacterial infection? J Funct Biomater . 2022 ; 13 ( 4 ): 264 . Crossref PubMed Google Scholar

34. Wojtowicz R , Henricson A , Nilsson KG , Crnalic S . Uncemented monoblock trabecular metal posterior stabilized high-flex total knee arthroplasty: similar pattern of migration to the cruciate-retaining design — a prospective radiostereometric analysis (RSA) and clinical evaluation of 40 patients (49 knees) 60 years or younger with 9 years’ follow-up . Acta Orthopaedica . 2019 ; 90 ( 5 ): 460 466 . Crossref PubMed Google Scholar

Author contributions

V. Khetan: Conceptualization, Data curation, Writing – original draft, Writing – review & editing.

I. Baxter: Data curation.

M. Hampton: Writing – review & editing.

A. Spencer: Formal analysis.

A. Anderson: Conceptualization, Funding acquisition, Investigation, Methodology, Project administration, Writing – review & editing.

Funding statement

The authors disclose receipt of the following financial or material support for the research, authorship, and/or publication of this article: financial support for statistical services from the surgical division, The Rotherham NHS Foundation Trust, Rotherham, UK.

ICMJE COI statement

The authors disclose receipt of the following financial or material support for the research, authorship, and/or publication of this article: I. Baxter, A. Spencer, and V. Khetan report financial support for statistical services from the Research Fund of the surgical division, The Rotherham NHS Foundation Trust, Rotherham, UK.

Data sharing

The data that support the findings for this study are available to other researchers from the corresponding author upon reasonable request.

Acknowledgements

The authors would like to acknowledge the contribution of Miss A Rees and Mr N Garneti towards the surgical cases included in the study.

Ethical review statement

Ethical approval was not required as data previously collected and stored in hospital servers (with patients’ approval) was used to conduct the study. Data from the NJR was sourced from their website.

Open access funding

The authors confirm that the open access funding for this manuscript was self-funded.

Social media

Follow V. Khetan on X @vatsal_khetan

Follow I. Baxter on X @I_a_n_baxter

Follow M. Hampton on X @ hampton_ortho

© 2024 Khetan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND 4.0) licence, which permits the copying and redistribution of the work only, and provided the original author and source are credited. See https://creativecommons.org/licenses/by-nc-nd/4.0/